AmerisourceBergen (NYSE:ABC) fiscal Q4 results:
Revenue: $45,637.8M (+5.4%); Pharmaceutical Distribution Services: $43,865.4M (+5.1%).
Net income: $132.3M (-31.8%); non-GAAP net income: $338.2M (+7.3%); EPS: $0.63 (-41.1%); non-GAAP EPS: $1.61 (+11.0%).
Cash flow ops (FY): $2,344.0M (+66.1%).
Fiscal 2020 guidance: Revenue growth: Mid-to-high single digit; non-GAAP operating income growth: low-to-mid-single digit; non-GAAP free cash flow: ~$1.5B.
Previously: AmerisourceBergen EPS beats by $0.03, beats on revenue (Nov. 7)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.